Aravive Inc (NASDAQ:ARAV)
| 0.133 Delayed Data As of Sep 29 |  +0.0007 / +0.53%Today’s Change | 0.11 Today|||52-Week Range 2.46 | -89.92% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $9.8M |
Company Description
Aravive, Inc. operates as a clinical stage biotechnology company, which engages in the development of transformative treatments designed to halt the progression of life threatening disease, including cancer and fibrosis. The company was founded on December 10, 2008 and is headquartered in Houston, TX.
Contact Information
Aravive, Inc. River Oaks Tower Houston Texas 77098 |
Employees
Shareholders
| Individual stakeholders | 41.60% |
| Mutual fund holders | 2.34% |
| Other institutional | 19.58% |
Top Executives
| Gail Frances McIntyre | President, Chief Executive Officer & Director |
| Leonard Scott Dove | Chief Operating Officer |
| Rudy C. Howard | Chief Financial Officer |
| Robert B. Geller | Chief Medical Officer |
| Maria Carolina Petrini | Chief Commercial Officer |
